QT Imaging has posted Q4 and year-end revenue increases.
For the period (end-December 31, 2024), the company reported fourth-quarter revenue of $847,000, compared with $5,000 in the same period for 2023. For the year, the company reported revenue of $4.9 million compared with $40,000 in 2023.
For the quarter, QT Imaging posted a net loss of $3.5 million, compared with a net loss of $1.5 million in 2023. Net loss for the year was $9 million, compared with $6.1 million in 2023.
Earlier this year, Nasdaq suspended trading of the company's stock; QT Imaging intends to apply for relisting. In February, the firm secured a credit agreement with Lynrock Lake Master Fund LP for $10.1 million. In March, it entered into an agreement with Canon Medical Systems to help increase its internal manufacturing capability.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
